iAnthus Capital Holdings (CSE: IAN) (OTCQB: ITHUF) - Investor Dashboard
|Employees:||540 (April 2019)|
iAnthus Capital Holdings – Management Team
Hadley Ford – CEO and Director
Former Goldman Sachs Investment Banker and CEO of ProCure
Nine years as CEO of ProCure Treatment Centers, a proton therapy cancer treatment company with over 300 employees and $100 million of annual revenues. Executed over 150 transactions in 14 years as an investment banker at First Boston, Bank of America, and Goldman Sachs. Quoted and profiled by the New York Times, Bloomberg News, the Wall Street Journal, National Public Radio, and various other media publications . M.B.A. from Stanford University, the Graduate School of Business. B.S. in Business Admin from Boston University.
Randy Maslow – President and Director
Former Executive at XO Communications; Technology Attorney and Entrepreneur
Co-founder, board member, and Senior Vice President of Business Development and General Counsel for the internet service provider that became XO Communications, which was eventually sold to Verizon for $1.8 billion in February 2016. Co-Founder of Internet Gaming Entertainment U.S., which had +$100 million in annual revenues. Served as Senior Vice President and General Counsel and board member. Founder of Electric Ventures, a New York based angel investor network for startup technology companies. J.D from Rutgers University School of Law. A.B. from Cornell University.
Beth Stavola – Chief Strategy Officer and Director
Former COO, President of US Operations of MPX Bioceutical
Ms. Stavola, an experienced cannabis entrepreneur, is the founder of cannabis brand Health for Life and Melting Point Extracts (MPX). She also started the company CBD for Life. Prior to entering the cannabis space, she worked with Jefferies and Company. Ms. Stavola also works to promote women in the cannabis space.
Dr. Richard Boxer – Chief Medical Officer
Clinical Professor and Scholar at UCLA and University of Wisconsin, Finalist for Surgeon General under the Clinton and Bush Administrations
Professor and Scholar at the David Geffen School of Medicine at UCLA and the University of Wisconsin School of Medicine and Public Health. Advisor to the Clinton White House in 1993. Served on the National Cancer Advisory Board and the National Institute of Diabetes, Digestive and Kidney Diseases at the National Institute of Health. Recipient of a Presidential Citation and a Cancer Research Award from the American Urological Association. M.D. from UCLA David Geffen School of Medicine and University of Wisconsin – Madison.
Julius Kalcevich – CFO
Former Partner at BG Partners Corp; +15 Years of Banking Experience in U.S./Canada
Served as partner and leader of cannabis investments at BG Partners Corp., a Toronto based merchant bank focused on early stage and venture financings. Former investment banking director at CIBC and Dundee Capital Markets, where Mr. Kalcevich worked on over 40 transactions worth +$5 billion. Extensive knowledge of cross border transactions and financings. M.B.A. from Columbia Business School. B.A. from McGill University.
Neil Calvesbert – Chief Marketing Officer
Former Chief Growth and Marketing Officer for Nicopure Labs
As Chief Marketing Officer of iAnthus, Mr. Calvesbert is in charge of developing and executing brand vision and strategies. Prior to joining iAnthus, he was the Chief Growth and Marketing Officer for Nicopure Labs and Vice President of Global Marketing for Monster Energy Beverages. He also has experience as the CEO of Fox Racing.
Significant Insider Ownership
Hadley Ford, CEO
1.813mm Class A shares, 259K common shares and 150K options
Randy Maslow, President
2.713mm Class A shares, 250K common shares and 150K options
Beth Stavola, Chief Strategy Officer
2.19mm common shares, 832K warrants and options
John Henderson, CDO
1.4mm Class A shares, 170K common shares and 150K options
Julius Kalcevich, CFO
415K common shares and 1.3 million options
Carlos Perea, COO
335K common shares and 391K Class A shares
Pat Tiernan, EVP of Operations
250K common shares
Richard Boxer, Director
260K Class A shares. 174K common shares and 100K options
Paul Rosen, Director
70K common shares and 75K options
Robert Petch, Director
125K common shares
Robert Galvin, Director
126K common shares and 125K options
New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. iAnthus Capital Holdings, Inc., is a client of NCV Media, LLC. Read our full disclaimer.